Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107147313 | 10714731 | 3 | F | 201412 | 20160319 | 20150115 | 20160331 | EXP | AU-ABBVIE-14P-008-1326120-00 | ABBVIE | 64.18 | YR | F | Y | 0.00000 | 20160331 | MD | COUNTRY NOT SPECIFIED | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107147313 | 10714731 | 1 | PS | OMBITASVIR/PARITAPREVIR/RITONAVIR | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 206619 | TABLET | QD | |||||||||
| 107147313 | 10714731 | 2 | SS | DASABUVIR | DASABUVIR | 1 | Oral | 206619 | TABLET | BID | |||||||||
| 107147313 | 10714731 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 0 | 600 | MG | TABLET | BID | |||||||
| 107147313 | 10714731 | 4 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 107147313 | 10714731 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107147313 | 10714731 | 1 | Chronic hepatitis C |
| 107147313 | 10714731 | 2 | Chronic hepatitis C |
| 107147313 | 10714731 | 3 | Chronic hepatitis C |
| 107147313 | 10714731 | 4 | Cardiac disorder |
| 107147313 | 10714731 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107147313 | 10714731 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107147313 | 10714731 | Abdominal pain | |
| 107147313 | 10714731 | Adverse drug reaction | |
| 107147313 | 10714731 | Bile duct obstruction | |
| 107147313 | 10714731 | Cholelithiasis | |
| 107147313 | 10714731 | Hepatic enzyme increased | |
| 107147313 | 10714731 | Hepatomegaly | |
| 107147313 | 10714731 | Hyperbilirubinaemia | |
| 107147313 | 10714731 | Jaundice | |
| 107147313 | 10714731 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107147313 | 10714731 | 1 | 20141119 | 201501 | 0 | |
| 107147313 | 10714731 | 2 | 20141119 | 201501 | 0 | |
| 107147313 | 10714731 | 3 | 20141119 | 201501 | 0 |